Susquehanna International Group’s DNA X Inc SONM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,520
Closed -$16.5K 13532
2025
Q3
$16.5K Buy
+1,520
New +$17.6K ﹤0.01% 12069
2025
Q2
Sell
-860
Closed -$33.1K 13644
2025
Q1
$33.1K Buy
+860
New +$41K ﹤0.01% 11984
2022
Q4
Sell
-77
Closed -$7K 13590
2022
Q3
$7K Sell
77
-613
-89% -$76.1K ﹤0.01% 12840
2022
Q2
$68K Buy
690
+413
+149% +$46.6K ﹤0.01% 11788
2022
Q1
$43K Buy
277
+113
+69% +$15.3K ﹤0.01% 12375
2021
Q4
$27K Buy
+164
New +$49.8K ﹤0.01% 12764

Other funds holding SONM

Susquehanna International Group's SONM Position: Q4 2025 in Review

Susquehanna International Group sold out of DNA X Inc (SONM) in Q4 2025, closing a stake of 1,520 shares — an estimated $16.5K sold.

Susquehanna International Group first reported a position in SONM in Q4 2021 and held it in 6 quarters. The position peaked at $68K in Q2 2022. 8 funds tracked by Wall St. Rank hold SONM as of Q4 2025.

  • Susquehanna International Group reported no remaining DNA X Inc position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 1,520 DNA X Inc shares in Q4 2025, an estimated $16.5K.
  • Susquehanna International Group first reported a position in DNA X Inc in Q4 2021 and held it in 6 quarters.
  • Susquehanna International Group's DNA X Inc position peaked at $68K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held DNA X Inc as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.